SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-005768
Filing Date
2024-04-25
Accepted
2024-04-25 16:10:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240425xdefa14a.htm DEFA14A 13585
2 GRAPHIC tmb-20240425xdefa14a_bg001.jpg GRAPHIC 170465
3 GRAPHIC tmb-20240425xdefa14a_bg002.jpg GRAPHIC 114648
  Complete submission text file 0001558370-24-005768.txt   407505
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40925 | Film No.: 24876369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)